ARCHIVES

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008

NCAB Honors Member Who Was In Stockholm

December 9, 1988

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010